Effects of Insulin Aspart 30 versus Glimepiride on B Islet Cell Function in Patients with Newly Diagnosed Type 2 Diabetes
- VernacularTitle:门冬胰岛素30、格列美脲对初诊2型糖尿病患者胰岛功能的影响研究
- Author:
Song LU
;
Chengjian WANG
;
Rongxi HUANG
- Publication Type:Journal Article
- Keywords:
Diabetes;
HbA1c;
Insulin resistance;
Insulin sensitivity index
- From:
China Pharmacy
2005;0(17):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To discuss the effects of different intensive treatment on B islet cell function in patients with newly diagnosed type 2 diabetes. METHODS: 54 patients who had been newly diagnosed as having type 2 diabetes were randomly assigned to receive Insulin aspart 30 or Glimepiride combined with Metformin (oral hypoglycemic agent). The blood glucose, glycosylated hemoglobin (HbA1c), and B islet cell function in two groups before and after treatment were followed. RESULTS: After treatment, blood glucose and glycosylated hemoglobin (HbA1c) in both group lowered significantly (P
